By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GW Pharmaceuticals Ltd. 

Porton Down Science Park

Salisbury  Wiltshire  SP4 0JQ  United Kingdom
Phone: 44-1980-619000 Fax: +44-1980-619111



Company News
GW Pharmaceuticals Announces Epidiolex® Receives Orphan Designation From European Medicines Agency For The Treatment Of Dravet Syndrome 10/22/2014 7:13:35 AM
GW Pharmaceuticals Announces New Physician Reports Of Epidiolex® Treatment Effect In Children And Young Adults With Treatment-Resistant Epilepsy 10/14/2014 9:28:38 AM
Cannabis Biopharma GW Pharmaceuticals Sees Disappointing Data For Colitis Drug 10/14/2014 7:51:11 AM
GW Pharmaceuticals Research And Development Day Details 9/29/2014 11:18:49 AM
GW Pharmaceuticals To Present At The Leerink Rare Disease Roundtable 2014 9/24/2014 7:24:15 AM
GW Pharmaceuticals Reports 2014 Third Quarter Financial Results 8/6/2014 7:55:05 AM
GW Pharmaceuticals To Report Q3 2014 Financial Results And Host Conference Call On 6 August, 2014 7/30/2014 9:08:06 AM
GW Pharmaceuticals Announces The Closing Of U.S. Public Offering Of American Depositary Shares (Adss) Totaling Approximately $169.8 Million On The NASDAQ Global Market And Full Exercise Of Underwriters' Option To Purchase Additional Adss 6/26/2014 7:41:40 AM
GW Pharmaceuticals Eyes $148 Million In NASDAQ Offering 6/19/2014 6:17:37 AM
GW Pharmaceuticals Announces Proposed Public Offering Of ADSs 6/18/2014 8:44:39 AM